bluebird bio
BLUE
$0.90
Share price
-0.39%
Change (1 day)
-77.89%
Change (1 year)
Operating Margin for bluebird bio (BLUE)
Operating Margin as of May 2024 (TTM): -7,407.86%
According to bluebird bio 's latest financial reports and stock price the company's current Operating Margin is -7,407.86%. At the end of 2021 the company had an Operating Margin of -15,431.73%.
Operating Margin history for bluebird bio from 2012 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -15,431.73% | 6046.42% |
| 2020 | -251.07% | -86.19% |
| 2019 | -1,817.79% | 74.36% |
| 2018 | -1,042.57% | 11.02% |
| 2017 | -939.09% | -78.08% |
| 2016 | -4,284.96% | 263.05% |
| 2015 | -1,180.25% | 396.91% |
| 2014 | -237.52% | 92.14% |
| 2013 | -123.62% | -98.23% |
| 2012 | -6,975.29% | 306.3% |
| 2011 | -1,716.78% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | 18.21% | -100.25% | 🇫🇷 France |
 Merck MRK | 27.73% | -100.37% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -160.78% | -97.83% | 🇺🇸 USA |
 Acceleron Pharma XLRN | -226.57% | -96.94% | 🇺🇸 USA |
 GlycoMimetics
GLYC | -34,735.80% | 368.90% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -100.07% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.